Advertisement
Advertisement

BWAY

BWAY logo

Brainsway Ltd. - ADR

15.54
USD
-0.23
-1.46%
Sep 15, 10:42 UTC -4
Open

Brainsway Ltd. - ADR Profile

About

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel.

Info & Links

CEO

Hadar Levy

Headquarters

16 HARTUM STREET, RAD TOWER,14TH FLOOR, HAR HAHOTZVIM
JERUSALEM, L3 9777516, ISRAEL

Sector

Medical

Auditor

KOST FORER GABBAY & KASIERER

Share holders

1

Employees

120

Brainsway Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

293.82M

Enterprise Value

225.65M

Enterprise Value/EBITDA(ttm)

59.32

Price to Earnings Ratio(ttm)

61.23

Price to Sales(ttm)

6.53

Price to Book(mrq)

4.42

Price to Cash(ytd)

63.84

Profitability

Gross Margin(ttm)

74.48%

Operating Margin(ttm)

11.60%

Profit Margin(ttm)

11.38%

Return on Equity(ttm)

8.97%

Return on Invested Capital(ttm)

8.70%

Return on Assets(ttm)

5.65%

Income Statement

Revenue(ttm)

46.08M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

34.34M

EBITDA(ttm)3

3.80M

Net Income Available to Common(ttm)

5.34M

Diluted EPS(ttm)

0.26

Share Statistics

Beta (5Y Monthly)

1.34

52-Week Change

88.99%

S&P 500 52-Week Change

17.41%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

15.31M

% Held by Insiders

19.00%

% Held by Institutions

30.11%

Balance Sheet

Total Cash(mrq)

78.25M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.51%

Quick Ratio(mrq)

3.34%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

0.86

Free Cash Flow(ytd)

15.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement